Pricing Agreement Sample Contracts

Share Cite Term
Link

Embed (HTML)
Pricing Agreement (September 29th, 2017)
Restoration Robotics Inc – First Amendment to Component Pricing Agreement (September 1st, 2017)

This First Amendment (First Amendment) is made and entered into as of August 30, 2017 (First Amendment Effective Date), by and between RESTORATION ROBOTICS, INC. (RR or Restoration Robotics) and EVOLVE MANUFACTURING TECHNOLOGIES INC. (Component Supplier), and amends that certain Component Pricing Agreement, dated August 1, 2016, between RR and Component Supplier (Agreement).

Restoration Robotics Inc – Component Pricing Agreement (September 1st, 2017)

This Component Pricing Agreement (this Agreement) is between Restoration Robotics, Inc., a Delaware corporation with a principal address at 128 Baytech Drive, San Jose, California 95134 (Restoration Robotics) and Evolve Manufacturing Technologies Inc., a company having a place of business at 47300 Bayside Parkway, Fremont, CA 94538 (Component Supplier) and is effective as of August 1, 2016 (the Effective Date). Restoration Robotics and Component Supplier may be each referred to herein as a Party or collectively as the Parties.

Pricing Agreement (August 10th, 2017)

Aetna Inc., a Pennsylvania corporation (the "Company"), proposes, subject to the terms and conditions stated herein and in the Underwriting Agreement, dated May 1, 2012 (the "Underwriting Agreement"), to issue and sell to the Underwriters named in Schedule I hereto (the "Underwriters") the debt securities specified in Schedule II hereto (the "Designated Securities"). Each of the provisions of the Underwriting Agreement is incorporated herein by reference in its entirety, and shall be deemed to be a part of this Agreement to the same extent as if such provisions had been set forth in full herein; and each of the representations and warranties set forth therein shall be deemed to have been made at and as of the date of this Pricing Agreement. Each reference to the Representatives herein and in the provisions of the Underwriting Agreement so incorporated by reference shall be deemed to refer to you. Unless otherwise defined herein, terms defined in the Underwriting Agreement are used here

Pricing Agreement (July 14th, 2017)
Pricing Agreement (June 26th, 2017)
China Telecom – CHINA TELECOM CORPORATION LIMITED and CHINA TOWER CORPORATION LIMITED COMMERCIAL PRICING AGREEMENT (April 28th, 2017)

This Commercial Pricing Agreement (the Agreement) is entered into by and between the following two parties on 8 July 2016 in Beijing, China:

China Mobile – CHINA MOBILE COMMUNICATION COMPANY LIMITED and CHINA TOWER CORPORATION LIMITED COMMERCIAL PRICING AGREEMENT (April 27th, 2017)

This Commercial Pricing Agreement (the Agreement) is entered into by and between the following two parties on 8 July 2016 in Beijing, China:

CHINA UNITED NETWORK COMMUNICATIONS CORPORATION LIMITED and CHINA TOWER CORPORATION LIMITED COMMERCIAL PRICING AGREEMENT (April 21st, 2017)

This Commercial Pricing Agreement (the Agreement) is entered into by and between the following two parties on 8 July 2016 in Beijing, China:

Pricing Agreement (November 23rd, 2016)

Abbott Laboratories, an Illinois corporation (the Company), proposes, subject to the terms and conditions stated herein and in the Underwriting Agreement, dated March 5, 2015 (the Underwriting Agreement), between the Company and the Representatives of the several Underwriters to issue and sell to the Underwriters named in Schedule I hereto (the Underwriters) the Securities specified in Schedule II hereto (the Designated Securities). Each of the provisions of the Underwriting Agreement is incorporated herein by reference in its entirety and shall be deemed to be a part of this Agreement to the same extent as if such provisions had been set forth in full herein; and each of the representations and warranties set forth therein shall be deemed to have been made at and as of the date of this Pricing Agreement, except that each representation and warranty which refers to the Prospectus in Section 1 of the Underwriting Agreement shall be deemed to be a representation or warranty as of the dat

Pricing Agreement (November 4th, 2016)
Pricing Agreement (July 12th, 2016)
Pricing Agreement (June 7th, 2016)

Aetna Inc., a Pennsylvania corporation (the "Company"), proposes, subject to the terms and conditions stated herein and in the Underwriting Agreement, dated May 1, 2012 (the "Underwriting Agreement"), to issue and sell to the Underwriters named in Schedule I hereto (the "Underwriters") the debt securities specified in Schedule II hereto (the "Designated Securities"). Each of the provisions of the Underwriting Agreement is incorporated herein by reference in its entirety, and shall be deemed to be a part of this Agreement to the same extent as if such provisions had been set forth in full herein; and each of the representations and warranties set forth therein shall be deemed to have been made at and as of the date of this Pricing Agreement. Each reference to the Representatives herein and in the provisions of the Underwriting Agreement so incorporated by reference shall be deemed to refer to you. Unless otherwise defined herein, terms defined in the Underwriting Agreement are used here

Coca-Cola Bottling Co. Consolidated – April 6, 2016 Coca-Cola Bottling Co. Consolidated Senior Vice President and CFO 4100 Coca-Cola Plaza Charlotte, NC 28211 Re: Incidence Pricing Agreement Dear Mr. Deal: (April 8th, 2016)

This letter (this "Agreement") confirms our incidence pricing program with Coca-Cola Bottling Co. Consolidated ("Bottler") starting in 2016 (the "Program") for the Term defined below. The Program described below applies only to concentrate that the Bottler purchases from The Coca-Cola Company through its Coca-Cola North America division (CCNA) for producing the beverages under the "Brands" listed in Attachment A that ultimately will be sold as finished goods to your customers who resell the finished goods directly or indirectly to retailers and consumers who are located in the respective authorized territories for the Brands, as permitted in the respective agreements between The Coca-Cola Company ("Company") or by and through CCNA and the Bottler for the Brands ("Covered Sales"). The Program described below will not apply to concentrate that the Bottler purchases from CCNA that is used to manufacture finished goods for resale to CCNA or to authorized Coca-Cola bottlers that are not own

Pricing Agreement (March 7th, 2016)
Pricing Agreement (September 25th, 2015)
Pricing Agreement (May 28th, 2015)
Emerson Electric – EMERSON ELECTRIC CO. Debt Securities Underwriting Agreement Standard Provisions May 18, 2015 (May 20th, 2015)

The terms and rights of any particular issuance of Designated Securities shall be as specified in the Pricing Agreement relating thereto and in or pursuant to the Indenture (the Indenture), dated as of December 10, 1998, between the Company and The Bank of New York Mellon Trust Company, N.A., as Trustee (successor to The Bank of New York). The Pricing Agreement, including the provisions incorporated therein by reference, is herein referred to as the Underwriting Agreement. Unless otherwise defined herein, terms defined in the Pricing Agreement are used herein as therein defined.

Pricing Agreement (March 17th, 2015)
Pricing Agreement (March 9th, 2015)
BiondVax Pharmaceuticals Ltd. – Reverse Equity Pricing Agreement (December 29th, 2014)

This REVERSE EQUITY PRICING AGREEMENT ("Agreement") dated as of November 13, 2013 between YA Global Investments, L.P, a limited partnership organized and existing under the laws of the Cayman Islands (the "Investor"), and BiondVax Pharmaceuticals Ltd., a public company organized and existing under the laws of Israel (the "Company"). Each of the above mentioned parties to this Agreement shall be referred to as a "Party" and all of such Parties as the "Parties."

Pricing Agreement (November 14th, 2014)
BiondVax Pharmaceuticals Ltd. – Reverse Equity Pricing Agreement (November 13th, 2014)

This REVERSE EQUITY PRICING AGREEMENT ("Agreement") dated as of November 13, 2013 between YA Global Investments, L.P, a limited partnership organized and existing under the laws of the Cayman Islands (the "Investor"), and BiondVax Pharmaceuticals Ltd., a public company organized and existing under the laws of Israel (the "Company"). Each of the above mentioned parties to this Agreement shall be referred to as a "Party" and all of such Parties as the "Parties."

Pricing Agreement (November 7th, 2014)

Aetna Inc., a Pennsylvania corporation (the "Company"), proposes, subject to the terms and conditions stated herein and in the Underwriting Agreement dated May 1, 2012 (the "Underwriting Agreement"), to issue and sell to the Underwriters named in Schedule I hereto (the "Underwriters") the debt securities specified in Schedule II hereto (the "Designated Securities"). Each of the provisions of the Underwriting Agreement is incorporated herein by reference in its entirety, and shall be deemed to be a part of this Agreement to the same extent as if such provisions had been set forth in full herein; and each of the representations and warranties set forth therein shall be deemed to have been made at and as of the date of this Pricing Agreement. Each reference to the Representatives herein and in the provisions of the Underwriting Agreement so incorporated by reference shall be deemed to refer to you. Unless otherwise defined herein, terms defined in the Underwriting Agreement are used herei

Production Pricing Agreement (November 7th, 2014)

This Production Pricing Agreement (Pricing Agreement) is entered into effective as of the date last signed below (PA Effective Date) by and between Tesla Motors, Inc., a Delaware corporation located at 3500 Deer Creek Road, Palo Alto, California, 94304 (Tesla) and Panasonic Corporation, a Japanese corporation located at 1006 Kadoma, Kadoma City, Osaka, 571-8506, Japan (Seller). Tesla and Seller are each referred to herein as a Party and collectively as the Parties. The Parties enter into this Pricing Agreement in connection with, and subject to, the General Terms and Conditions dated October 1, 2014 (the General Terms). Terms used herein with initial capitalization have the meanings specified where used or in the General Terms.

Pricing Agreement (October 1st, 2014)

Reference is made to the Remarketing Agreement, dated August 26, 2014 (the Remarketing Agreement), among MetLife, Inc., a Delaware corporation, Deutsche Bank Trust Company Americas, not individually but solely as Stock Purchase Contract Agent, and Deutsche Bank Securities Inc. (together with the institutions appointed as Remarketing Agents pursuant to Section 8 thereof, the Remarketing Agents) in connection with the remarketing of the securities specified in the Final Term Sheet set forth as Annex A hereto (the Remarketed Securities). Unless otherwise defined herein, terms defined in the Remarketing Agreement are used herein as therein defined.

Pricing Agreement (August 1st, 2014)

Brandywine Realty Trust, a Maryland real estate investment trust (the Company), and Brandywine Operating Partnership, L.P., a Delaware limited partnership and subsidiary of the Company (the Operating Partnership), proposes, subject to the terms and conditions stated herein and in the Underwriting Agreement, dated July 28, 2014 (the Underwriting Agreement), among the Company, the Operating Partnership and you for the Company to issue and sell to the Underwriters named in Schedule I hereto (the Underwriters) the common shares of beneficial interests of the Company specified in Schedule I hereto (the Designated Shares, consisting of Firm Shares and any Optional Shares the Underwriters may elect to purchase). Each of the provisions of the Underwriting Agreement is incorporated herein by reference in its entirety, and shall be deemed to be a part of this Agreement to the same extent as if such provisions had been set forth in full herein, and each of the representations and warranties set f

Pfizer Inc. Debt Securities Underwriting Agreement (May 15th, 2014)

From time to time Pfizer Inc., a Delaware corporation (the Company), proposes to enter into one or more Pricing Agreements (each a Pricing Agreement) in the form of Annex I hereto, with such additions and deletions as the parties thereto may determine, and subject to the terms and conditions stated herein and therein, to issue and sell to the firms named in Schedule I to the applicable Pricing Agreement (such firms constituting the Underwriters with respect to such Pricing Agreement and the securities specified therein) certain of its debt securities (the Securities) specified in Schedule II to such Pricing Agreement (with respect to such Pricing Agreement, the Designated Securities).

Pricing Agreement (March 7th, 2014)

Aetna Inc., a Pennsylvania corporation (the "Company"), proposes, subject to the terms and conditions stated herein and in the Underwriting Agreement dated May 1, 2012 (the "Underwriting Agreement"), to issue and sell to the Underwriters named in Schedule I hereto (the "Underwriters") the debt securities specified in Schedule II hereto (the "Designated Securities"). Each of the provisions of the Underwriting Agreement is incorporated herein by reference in its entirety, and shall be deemed to be a part of this Agreement to the same extent as if such provisions had been set forth in full herein; and each of the representations and warranties set forth therein shall be deemed to have been made at and as of the date of this Pricing Agreement. Each reference to the Representatives herein and in the provisions of the Underwriting Agreement so incorporated by reference shall be deemed to refer to you. Unless otherwise defined herein, terms defined in the Underwriting Agreement are used herei

Underwriting Agreement Standard Provisions (March 6th, 2014)

To the Representatives of the several Underwriters named in the respective Pricing Agreements hereinafter described

Coca-Cola Bottling Co. Consolidated – Re: Incidence Pricing Agreement (December 26th, 2013)

This letter confirms our plans to enter into an incidence pricing program (the Program) with Coca-Cola Bottling Co. Consolidated (Bottler) starting in 2014 for the Term defined below. The Program described below applies only to concentrate that the Bottler purchases from CCNA for producing the beverages under the Brands listed in Attachment A that ultimately will be sold as finished goods to your customers who resell the finished goods directly or indirectly to retailers and consumers who are located in the respective authorized territories for the Brands, as permitted in the respective agreements between The Coca-Cola Company (Company) or by and through CCNA and the Bottler for the Brands (Covered Sales). The Program described below will not apply to concentrate that the Bottler purchases from CCNA that is used to manufacture finished goods for resale to CCNA or to authorized Coca-Cola bottlers that are not owned and controlled by the Bottler (Excluded Sales).

Pricing Agreement (December 9th, 2013)
Pricing Agreement (December 3rd, 2013)
Pricing Agreement (September 6th, 2013)

Reference is made to the Remarketing Agreement, dated July 30, 2013 (the Remarketing Agreement), among MetLife, Inc., a Delaware Corporation, Deutsche Bank Trust Company Americas, not individually but solely as Stock Purchase Contract Agent, and Deutsche Bank Securities Inc. (together with the institutions appointed as Remarketing Agents pursuant to Section 8 thereof, the Remarketing Agents) in connection with the remarketing of the securities specified in the Final Term Sheet set forth as Annex A hereto (the Remarketed Securities). Unless otherwise defined herein, terms defined in the Remarketing Agreement are used herein as therein defined.

Pfizer Inc. Debt Securities Underwriting Agreement (June 3rd, 2013)

From time to time Pfizer Inc., a Delaware corporation (the Company), proposes to enter into one or more Pricing Agreements (each a Pricing Agreement) in the form of Annex I hereto, with such additions and deletions as the parties thereto may determine, and subject to the terms and conditions stated herein and therein, to issue and sell to the firms named in Schedule I to the applicable Pricing Agreement (such firms constituting the Underwriters with respect to such Pricing Agreement and the securities specified therein) certain of its debt securities (the Securities) specified in Schedule II to such Pricing Agreement (with respect to such Pricing Agreement, the Designated Securities).